Targeted Alpha Radionuclide Therapy (TAT)-Ac-225 Radiopharmaceuticals; [Hedefe Yönelik Alfa Radyonüklid Tedavisi (TAT)-Ac-225 Radyofarmasötikleri]

dc.contributor.authorOcak M.
dc.contributor.authorAkit A.A.
dc.contributor.authorÜnak P.
dc.date.accessioned2024-08-31T07:42:45Z
dc.date.available2024-08-31T07:42:45Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractTargeted alpha therapy (TAT) has become increasingly popular in recent years due to its easy application in patients with multiple metastases, its ability to treat multiple lesions simultaneously, and its ability to be used in combination with other treatment methods. TAT is performed by chelate conjugated-targeting molecules such as small peptides, peptidomimetics, monoclonal antibodies, biomolecules and small inhibitor molecules tagged with alpha-emiting radionuclides. It is possible to obtain Actinium-225 in various ways. The majority of Ac-225 used for preclinical research and clinical administration is radiochemically isolated from build-up sources of thorium-229. © 2023 The authors.en_US
dc.identifier.doi10.4274/nts.galenos.2023.0003
dc.identifier.endpage24en_US
dc.identifier.issn2149-6447
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85183303894en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage16en_US
dc.identifier.urihttps://doi.org10.4274/nts.galenos.2023.0003
dc.identifier.urihttps://hdl.handle.net/11454/104022
dc.identifier.volume9en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherGalenos Publishing Houseen_US
dc.relation.ispartofNuclear Medicine Seminarsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240831_Uen_US
dc.subjectAc-225en_US
dc.subjectAc-225 radiopharmaceuticalsen_US
dc.subjectTargeted alpha therapyen_US
dc.titleTargeted Alpha Radionuclide Therapy (TAT)-Ac-225 Radiopharmaceuticals; [Hedefe Yönelik Alfa Radyonüklid Tedavisi (TAT)-Ac-225 Radyofarmasötikleri]en_US
dc.typeArticleen_US

Dosyalar